SEC INSIDER TRANSACTIONS

COLGATE PALMOLIVE CO (CL) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

CL · COLGATE PALMOLIVE CO

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 33 filings · fetched 2026-11-13T17:00:23Z

Recent reported activity

0purchase rows on this page

5sale rows on this page

67matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-09-11Filed 2026-09-15	GRANT SHANEOfficer · COO, Americas Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Withholding of shares for payment of tax liability incident to the vesting of restricted stock units under the issuer's incentive compensation plan. References: F1	F WithholdingCommon Stock · Non-derivative	622D	86.8	Direct	Form 4 ↗0001225208-26-007826
2026-09-11Filed 2026-09-15	Fishbone BetsyOfficer · CLO and Secretary Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Withholding of shares for payment of tax liability incident to the vesting of restricted stock units under the issuer's incentive compensation plan. References: F1	F WithholdingCommon Stock · Non-derivative	404D	86.8	Direct	Form 4 ↗0001225208-26-007825
2026-08-24Filed 2026-08-26	Tsourapas PanagiotisOfficer · COO, CD, EMEA, APac, Skin Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 This amount includes 12,661 shares that were previously reported as directly beneficially owned. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	10,000D	92.0477	IndirectBy Trust	Form 4 ↗0001225208-26-007329
2026-08-06Filed 2026-08-07	CAHILL JOHN TDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of stock options awarded under the issuer's incentive compensation plan. F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.3712 to $93.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 Option became exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date. References: F1, F4	M Exercise / conversionStock Option (Right to Buy) · Derivative	4,170D	0	Direct	Form 4 ↗0001225208-26-007035
2026-08-06Filed 2026-08-07	CAHILL JOHN TDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of stock options awarded under the issuer's incentive compensation plan. F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.3712 to $93.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 Option became exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date. References: F2, F3	S Sale (market/private)Common Stock · Non-derivative	4,170D	93.3712	Direct	Form 4 ↗0001225208-26-007035
2026-08-06Filed 2026-08-07	CAHILL JOHN TDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of stock options awarded under the issuer's incentive compensation plan. F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.3712 to $93.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 Option became exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date. References: F1	M Exercise / conversionCommon Stock · Non-derivative	4,170A	71.56	Direct	Form 4 ↗0001225208-26-007035
2026-08-05Filed 2026-08-06	Wallace Noel R.Director · Officer · Chairman, President & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of stock options awarded under the issuer's incentive compensation plan. F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $91.50 to $92.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date. References: F1, F5	M Exercise / conversionStock Option (Right to Buy) · Derivative	161,021D	0	Direct	Form 4 ↗0001225208-26-007020
2026-08-05Filed 2026-08-06	Wallace Noel R.Director · Officer · Chairman, President & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of stock options awarded under the issuer's incentive compensation plan. F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $91.50 to $92.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date. References: F2, F4	S Sale (market/private)Common Stock · Non-derivative	161,021D	92.5215	Direct	Form 4 ↗0001225208-26-007020
2026-08-05Filed 2026-08-06	Wallace Noel R.Director · Officer · Chairman, President & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of stock options awarded under the issuer's incentive compensation plan. F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $91.50 to $92.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date. References: F1	M Exercise / conversionCommon Stock · Non-derivative	161,021A	72.29	Direct	Form 4 ↗0001225208-26-007020
2026-08-04Filed 2026-08-06	Wallace Noel R.Director · Officer · Chairman, President & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of stock options awarded under the issuer's incentive compensation plan. F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $91.50 to $92.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date. References: F1, F5	M Exercise / conversionStock Option (Right to Buy) · Derivative	161,021D	0	Direct	Form 4 ↗0001225208-26-007020
2026-08-04Filed 2026-08-06	Wallace Noel R.Director · Officer · Chairman, President & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of stock options awarded under the issuer's incentive compensation plan. F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $91.50 to $92.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date. References: F2, F3	S Sale (market/private)Common Stock · Non-derivative	161,021D	91.9179	Direct	Form 4 ↗0001225208-26-007020
2026-08-04Filed 2026-08-06	Wallace Noel R.Director · Officer · Chairman, President & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Exercise of stock options awarded under the issuer's incentive compensation plan. F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $91.50 to $92.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date. References: F1	M Exercise / conversionCommon Stock · Non-derivative	161,021A	72.29	Direct	Form 4 ↗0001225208-26-007020
2026-07-01Filed 2026-07-02	NORRINGTON LORRIE MDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. References: F1	A Award / grantCommon Stock · Non-derivative	293A	89.45	Direct	Form 4 ↗0001225208-26-006375
2026-07-01Filed 2026-07-02	Newman BrianDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. References: F1	A Award / grantCommon Stock · Non-derivative	209A	89.45	Direct	Form 4 ↗0001225208-26-006374
2026-07-01Filed 2026-07-02	BILBREY JOHN PDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. References: F1	A Award / grantCommon Stock · Non-derivative	265A	89.45	Direct	Form 4 ↗0001225208-26-006373
2026-06-16Filed 2026-06-17	GRANT SHANEOfficer · COO, Americas Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Withholding of shares for payment of tax liability incident to the vesting of restricted stock units under the issuer's incentive compensation plan. References: F1	F WithholdingCommon Stock · Non-derivative	23,347D	90.66	Direct	Form 4 ↗0001225208-26-006098
2026-05-15Filed 2026-05-18	Malcolm GregoryOfficer · EVP and Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	S Sale (market/private)Common Stock · Non-derivative	2,300D	88.44	Direct	Form 4 ↗0001225208-26-005447

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.